Pieris' Series A - II Round

Pieris raised a round of funding on January 01, 2006.

Pieris is an independent, clinical-staged biotechnology company advancing its proprietary Anticalin technology to create differentiated drugs that are safer and more effective than conventional approa…

Articles about Pieris' Series A - II Round: